Director
CurrentPathology and Toxicology yConsultancy. Supporting Early Discovery - exposure models benchmarked to relevant hazard endpoints - aiding molecule selection. The use of surrogate systems to support chemistry designBiopharma target identification - ISH and IHCRegulatory toxicology Studies - all stages of the development programme.Product Life Cycle Management.